CRL(CRL)
CRL
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
| Metric | FY2026E | FY2027E | FY2028E | FY2029E | FY2030E |
|---|---|---|---|---|---|
| Revenue Avg | $3.85B | $3.92B | $4.09B | $4.25B | $4.25B |
| Low | $3.83B | $3.87B | $4.08B | $4.20B | $4.20B |
| High | $3.87B | $4.02B | $4.10B | $4.33B | $4.33B |
| EBITDA Avg | $751M | $764M | $798M | $829M | $830M |
| Low | $747M | $755M | $797M | $820M | $820M |
| High | $755M | $784M | $800M | $845M | $846M |
| EBIT Avg | $430M | $437M | $457M | $475M | $475M |
| Low | $427M | $432M | $456M | $469M | $469M |
| High | $432M | $449M | $458M | $484M | $484M |
| Net Income Avg | $549M | $607M | $447M | $724M | $758M |
| Low | $543M | $590M | $435M | $714M | $747M |
| High | $555M | $625M | $817M | $742M | $777M |
| EPS Avg | $11.09 | $12.33 | $13.44 | $14.61 | $15.30 |
| Low | $10.95 | $11.91 | $8.77 | $14.40 | $15.08 |
| High | $11.20 | $12.60 | $16.48 | $14.97 | $15.68 |
| Analysts (Rev / EPS) | 8 / 10 | 11 / 10 | 11 / 5 | 5 / 1 | 5 / 1 |
| Metric | Q2 2026 | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 | Q1 2028 |
|---|---|---|---|---|---|---|---|---|
| Revenue Avg | $978M | $938M | $938M | $976M | $978M | $982M | $984M | $1.01B |
| Low | $960M | $921M | $923M | $960M | $962M | $965M | $968M | $992M |
| High | $1.01B | $986M | $971M | $1.01B | $1.01B | $1.02B | $1.02B | $1.04B |
| EBITDA Avg | $191M | $183M | $183M | $190M | $191M | $191M | $192M | $197M |
| Low | $187M | $180M | $180M | $187M | $188M | $188M | $189M | $194M |
| High | $197M | $192M | $190M | $197M | $198M | $198M | $199M | $204M |
| EBIT Avg | $109M | $105M | $105M | $109M | $109M | $110M | $110M | $113M |
| Low | $107M | $103M | $103M | $107M | $107M | $108M | $108M | $111M |
| High | $113M | $110M | $108M | $113M | $113M | $113M | $114M | $117M |
| Net Income Avg | $134M | $149M | $159M | $134M | $148M | $156M | $162M | $148M |
| Low | $131M | $147M | $155M | $131M | $145M | $153M | $159M | $145M |
| High | $146M | $151M | $166M | $140M | $155M | $164M | $170M | $155M |
| EPS Avg | $2.73 | $3.05 | $3.24 | $2.74 | $3.02 | $3.19 | $3.31 | $3.03 |
| Low | $2.67 | $3.00 | $3.17 | $2.68 | $2.96 | $3.13 | $3.24 | $2.97 |
| High | $2.98 | $3.08 | $3.39 | $2.87 | $3.16 | $3.34 | $3.47 | $3.17 |
| Analysts (Rev / EPS) | 6 / 9 | 6 / 9 | 3 / 4 | 3 / 5 | 3 / 3 | 3 / 3 | 3 / 5 | 3 / 7 |